Functional, biochemical, and pathological effects of repeated oral administration of ochratoxin A to rats

Chemical Research in Toxicology

Volumn 18, Issue 8, 2005, Pages 1242-1252

  Mally, Angela ^a   Völkel, Wolfgang ^a   Amberg, Alexander ^b   Kurz, Michael ^b   Wanek, Paul ^a   Eder, Erwin ^a   Hard, Gordon ^c   Dekant, Wolfgang ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^c NTP Archives   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOCHEMICAL MARKER; CYCLINE; MYCOTOXIN; OCHRATOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS; CARCINOGENICITY; CELL PROLIFERATION; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG EFFECT; EPITHELIUM CELL; HISTOPATHOLOGY; KIDNEY PROXIMAL TUBULE; MALE; NEPHROTOXICITY; NONHUMAN; PENICILLIUM; PRINCIPAL COMPONENT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; TOXICOKINETICS; URINE VOLUME;

ANIMALS; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; BLOTTING, WESTERN; BODY WEIGHT; CHROMATOGRAPHY, LIQUID; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; INTUBATION, GASTROINTESTINAL; KIDNEY; LIPID PEROXIDATION; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; OCHRATOXINS; ORGAN SIZE; PATTERN RECOGNITION, AUTOMATED; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, INBRED F344;

ANIMALIA; ASPERGILLUS; FUNGI; PENICILLIUM;

EID: 23844438306     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx049651p     Document Type: Article

References (70)

1. Ciegler, A., Fennell, D. J., Mintzlaff, H. J., and Leistner, L. (1972) Ochratoxin synthesis by Penicillium species. Naturwissenschaften 59, 365-366.
2. van der Merwe, K. J., Steyn, P. S., Fourie, L., Scott, D. B., and Theron, J. J. (1965) Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus Wilh. Nature 205, 1112-1113.
3. van Walbeek, W., Scott, P. M., Harwig, J., and Lawrence, J. W. (1969) Penicillium viridicatum Westling: a new source of ochratoxin A. Can. J. Microbiol. 15, 1281-1285.
4. Boorman, G. A., McDonald, M. R., Imoto, S., and Persing, R. (1992) Renal lesions induced by ochratoxin A exposure in the F344 rat. Toxicol. Pathol. 20, 236-245.
5. NTP (1989) Toxicology and carcinogenesis studies of ochratoxin A (CAS No. 303-47-9) in F344/N rats (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 358, 1-142.
6. Pfohl-Leszkowicz, A., Chakor, K., Creppy, E. E., and Dirheimer, G. (1991) DNA adduct formation in mice treated with ochratoxin A. IARC Sci. Publ., 245-253.
7. Castegnaro, M., Mohr, U., Pfohl-Leszkowicz, A., Esteve, J., Steinmann, J., Tillmann, T., Michelon, J., and Bartsch, H. (1998) Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. Int. J. Cancer 77, 70-75.
8. Gautier, J., Richoz, J., Welti, D. H., Markovic, J., Gremaud, E., Guengerich, F. P., and Turesky, R. J. (2001) Metabolism of ochratoxin A: absence of formation of genotoxic derivatives by human and rat enzymes. Chem. Res. Toxicol. 14, 34-45.
9. Gross-Steinmeyer, K., Weymann, J., Hege, H. G., and Metzler, M. (2002) Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin a in cultured rat and human primary hepatocytes. J. Agric. Food Chem. 50, 938-945.
10. Mally, A., Zepnik, H., Wanek, P., Eder, E., Dingley, K., Ihmels, H., Völkel, W., and Dekant, W. (2004) Ochratoxin A: lack of formation of covalent DNA adducts. Chem. Res. Toxicol. 17, 234-242.
11. Schlatter, C., Studer, R. J., and Rasonyi, T. (1996) Carcinogenicity and kinetic aspects of ochratoxin A. Food Addit. Contam., 43-44.
12. Bendele, A. M., Neal, S. B., Oberly, T. J., Thompson, C. Z., Bewsey, B. J., Hill, L. E., Rexroat, M. A., Carlton, W. W., and Probst, G. S. (1985) Evaluation of ochratoxin A for mutagenicity in a battery of bacterial and mammalian cell assays. Food Chem. Toxicol. 23, 911-918.
13. Follmann, W., and Lucas, S. (2003) Effects of the mycotoxin ochratoxin A in a bacterial and a mammalian in vitro mutagenicity test system. Arch. Toxicol. 77, 298-304.
14. Zepnik, H., Pahler, A., Schauer, U., and Dekant, W. (2001) Ochratoxin A-induced tumor formation: is there a role of reactive ochratoxin A metabolites? Toxicol. Sci. 59, 59-67.
15. Lock, E. A., and Hard, G. C. (2004) Chemically induced renal tubule tumors in the laboratory rat and mouse: review of the NCI/NTP database and categorization of renal carcinogens based on mechanistic information. Crit. Rev. Toxicol. 34, 211-299.
16. Hard, G. C. (1998) Mechanisms of chemically induced renal carcinogenesis in the laboratory rodent. Toxicol. Pathol. 26, 104-112.
17. Swenberg, J. A., and Lehman-McKeeman, L. D. (1999) a2u-Globulin associated nephropathy as a mechanism of renal tubular cell carcinogenesis in male rats. In IARC-Scientific Publications: Species differencies in thyroid, kidney and urinary bladder carcinogenesis (Capen, C. C., Dybing, E., Rice, J. M., and Wilbourn, J. D., Eds.) pp 95-118, International Agency on Cancer Research, Lyon, France.
18. IARC (1993) IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Vol. 56, Lyon, France.
19. Maaroufi, K., Zakhama, A., Baudrimont, I., Achour, A., Abid, S., Ellouz, F., Dhouib, S., Creppy, E. E., and Bacha, H. (1999) Karyomegaly of tubular cells as early stage marker of the nephrotoxicity induced by ochratoxin A in rats. Hum. Exp. Toxicol. 18, 410-315.
20. Munro, I. C., Moodie, C. A., Kuiper-Goodman, T., Scott, P. M., and Grice, H. C. (1974) Toxicologic changes in rats fed graded dietary levels of ochratoxin A. Toxicol. Appl. Pharmacol. 28, 180-188.
21. Galtier, P., Boneu, B., Charpenteau, J. L., Bodin, G., Alvinerie, M., and More, J. (1979) Physiopathology of haemorrhagic syndrome related to ochratoxin A intoxication in rats. Food Cosmet. Toxicol. 17, 49-53.
22. Berndt, W. O., and Hayes, A. W. (1979) In vivo and in vitro changes in renal function caused by ochratoxin A in the rat. Toxicology 12, 5-17.
23. Pfohl-Leszkowicz, A., Grosse, Y., Kane, A., Creppy, E. E., and Dirheimer, G. (1993) Differential DNA adduct formation and disappearance in three mouse tissues after treatment with the mycotoxin ochratoxin A. Mutat. Res. 289, 265-273.
24. Pfohl-Leskowicz, A., Bartsch, H., Azemar, B., Mohr, U., Esteve, J., and Castegnaro, M. (2002) Mesna protects rats against nephrotoxicity but not carcinogenicity induced by ochratoxin A, implicating two separate pathways. Facta Universitatis, Med. Biol. 9, 57-63.
25. Uchida, K., Fukuda, A., Kawakishi, S., Hiai, H., and Toyokuni, S. (1995) A renal carcinogen ferric nitrilotriacetate mediates a temporary accumulation of aldehyde-modified proteins within cytosolic compartment of rat kidney. Arch. Biochem. Biophys. 317, 405-411.
26. Zhang, D., Okada, S., Yu, Y., Zheng, P., Yamaguchi, R., and Kasai, H. (1997) Vitamin E inhibits apoptosis, DNA modification, and cancer incidence induced by iron-mediated peroxidation in Wistar rat kidney. Cancer Res. 57, 2410-2414.
27. Gautier, J. C., Holzhaeuser, D., Markovic, J., Gremaud, E., Schilter, B., and Turesky, R. J. (2001) Oxidative damage and stress response from ochratoxin a exposure in rats. Free Radical Biol. Med. 30, 1089-1098.
28. Wacker, M., Schuler, D., Wanek, P., and Eder, E. (2000) Development of a (32)P-postlabeling method for the detection of 1,N(2)-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in vivo. Chem. Res. Toxicol. 13, 1165-1173.
29. Zepnik, H., Volkel, W., and Dekant, W. (2003) Toxicokinetics of the mycotoxin ochratoxin A in F 344 rats after oral administration. Toxicol. Appl. Pharmacol. 192, 36-44.
30. Scholz, K., Pahler, A., Dekant, W., and Völkel, W. (2005) Development of a generic LC-MS/MS method for the detection of mercapturic acids as biomarkers of reactive metabolite formation. Arch. Pharmacol. 371 (Suppl. 1), 99.
31. Fowler, L. M., Foster, J. R., and Lock, E. A. (1994) Nephrotoxicity of 4-amino-3-S-glutathionylphenol and its modulation by metabolism or transport inhibitors. Arch. Toxicol. 68, 15-23.
32. Vamvakas, S., Kremling, E., and Dekant, W. (1989) Metabolic activation of the nephrotoxic haloalkene 1,1,2-trichloro-3,3,3-trifluoro-1-propene by glutathione conjugation. Biochem. Pharmacol. 38, 2297-2304.
33. Gartland, K. P., Bonner, F. W., and Nicholson, J. K. (1989) Investigations into the biochemical effects of region-specific nephrotoxins. Mol. Pharmacol. 35, 242-250.
34. Lindon, J. C., Holmes, E., Bollard, M. E., Stanley, E. G., and Nicholson, J. K. (2004) Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 9, 1-31.
35. Nicholson, J. K., Lindon, J. C., and Holmes, E. (1999) 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29, 1181-1189.
36. Holmes, E., Nicholls, A. W., Lindon, J. C., Connor, S. C., Connelly, J. C., Haselden, J. N., Damment, S. J., Spraul, M., Neidig, P., and Nicholson, J. K. (2000) Chemometric models for toxicity classification based on NMR spectra of biofluids. Chem. Res. Toxicol. 13, 471-478.
37. Chen, G. F., Ronis, M. J., Thomas, P. E., Flint, D. J., and Badger, T. M. (1997) Hormonal regulation of microsomal cytochrome P450 2C11 in rat liver and kidney. J. Pharmacol. Exp. Ther. 283, 1486-1494.
38. Pfohl-Leszkowicz, A., Pinelli, E., Bartsch, H., Mohr, U., and Castegnaro, M. (1998) Sex- and strain-specific expression of cytochrome P450s in ochratoxin A-induced genotoxicity and carcinogenicity in rats. Mol. Carcinog. 23, 76-85.
39. Sharma, M. C., Sharma, M. R., and Shapiro, B. H. (1998) A comparison of cytochrome P450-dependent testosterone 2alpha-hydroxylase in rat (P4502C11) and mouse (P4502alpha). Pharmacology 56, 71-79.
40. Cummings, B. S., Zangar, R. C., Novak, R. F., and Lash, L. H. (1999) Cellular distribution of cytochromes P-450 in the rat kidney. Drug Metab. Dispos. 27, 542-548.
41. Cummings, B. S., Parker, J. C., and Lash, L. H. (2001) Cytochrome p450-dependent metabolism of trichloroethylene in rat kidney. Toxicol. Sci. 60, 11-19.
42. Dai, J., Park, G., Wright, M. W., Adams, M., Akman, S. A., and Manderville, R. A. (2002) Detection and characterization of a glutathione conjugate of ochratoxin A. Chem. Res. Toxicol. 15, 1581-1588.
43. Boatman, R. J., English, J. C., Perry, L. G., and Bialecki, V. E. (1996) Differences in the nephrotoxicity of hydroquinone among Fischer 344 and Sprague-Dawley rats and B6C3F1 mice. J. Toxicol. Environ. Health 47, 159-172.
44. English, J. C., Perry, L. G., Vlaovic, M., Moyer, C., and O'Donoghue, J. L. (1994) Measurement of cell proliferation in the kidneys of Fischer 344 and Sprague-Dawley rats after gavage administration of hydroquinone. Fundam. Appl. Toxicol. 23, 397-406.
45. Monks, T., and Lau, S. (1994) Glutathione conjugation as a mechanism for the transport of reactive metabolites. In Conjugation-Dependent Carcinogenicity and Toxicity of Foreign Compounds (Anders, M., and Dekant, W., Eds.), Academic Press, San Diego, CA.
46. Nakagawa, Y., Kitahori, Y., Cho, M., Konishi, N., Tsumatani, K., Ozono, S., Okajima, E., Hirao, Y., and Hiasa, Y. (1998) Effect of hexachloro-1,3- butadiene on renal carcinogenesis in male rats pretreated with N-ethyl-N-hydroxyethylnitrosamine. Toxicol. Pathol. 26, 361-366.
47. Peters, M. M., Jones, T. W., Monks, T. J., and Lau, S. S. (1997) Cytotoxicity and cell-proliferation induced by the nephrocarcinogen hydroquinone and its nephrotoxic metabolite 2,3,5-(tris-glutathion-S-yl)hydroquinone. Carcinogenesis 18, 2393-2401.
48. Prescott-Mathews, J. S., Wolf, D. C., Wong, B. A., and Borghoff, S. J. (1997) Methyl tert-butyl ether causes alpha2u-globulin nephropathy and enhanced renal cell proliferation in male Fischer-344 rats. Toxicol. Appl. Pharmacol. 143, 301-314.
49. Larson, J. L., Wolf, D. C., and Butterworth, B. E. (1993) Acute hepatotoxic and nephrotoxic effects of chloroform in male F-344 rats and female B6C3F1 mice. Fundam. Appl. Toxicol. 20, 302-315.
50. Swenberg, J. A. (1993) Cell proliferation and chemical carcinogenesis: conference summary and future directions. Environ. Health Perspect. 101, 153-158.
51. Peters, M. M., Rivera, M. I., Jones, T. W., Monks, T. J., and Lau, S. S. (1996) Glutathione conjugates of tert-butyl-hydroquinone, a metabolite of the urinary tract tumor promoter 3-tert-butyl-hydroxyanisole, are toxic to kidney and bladder. Cancer Res. 56, 1006-1011.
52. Holmes, E., Nicholls, A. W., Lindon, J. C., Ramos, S., Spraul, M., Neidig, P., Connor, S. C., Connelly, J., Damment, S. J., Haselden, J., and Nicholson, J. K. (1998) Development of a model for classification of toxin-induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed. 11, 235-244.
53. Williams, R. E., and Lock, E. A. (2004) d-Serine-induced nephrotoxicity: possible interaction with tyrosine metabolism. Toxicology 201, 231-238.
54. Hauet, T., Baumert, H., Gibelin, H., Godart, C., Carretier, M., and Eugene, M. (2000) Citrate, acetate and renal medullary osmolyte excretion in urine as predictor of renal changes after cold ischaemia and transplantation. Clin. Chem. Lab. Med. 38, 1093-1098.
55. Foxall, P. J., Mellotte, G. J., Bending, M. R., Lindon, J. C., and Nicholson, J. K. (1993) NMR spectroscopy as a novel approach to the monitoring of renal transplant function. Kidney Int. 43, 234-245.
56. Baudrimont, I., Ahouandjivo, R., and Creppy, E. E. (1997) Prevention of lipid peroxidation induced by ochratoxin A in Vero cells in culture by several agents. Chem.-Biol. Interact. 104, 29-40.
57. Rahimtula, A. D., Bereziat, J. C., Bussacchini-Griot, V., and Bartsch, H. (1988) Lipid peroxidation as a possible cause of ochratoxin A toxicity. Biochem. Pharmacol. 37, 4469-4477.
58. Omar, R. F., Rahimtula, A. D., and Bartsch, H. (1991) Role of cytochrome P-450 in ochratoxin A-stimulated lipid peroxidation. J. Biochem. Toxicol. 6, 203-209.
59. Hoehler, D., Marquardt, R. R., McIntosh, A. R., and Xiao, H. (1996) Free radical generation as induced by ochratoxin A and its analogs in bacteria (Bacillus brevis). J. Biol. Chem. 271, 27388-27394.
60. Hoehler, D., Marquardt, R. R., McIntosh, A. R., and Hatch, G. M. (1997) Induction of free radicals in hepatocytes, mitochondria and microsomes of rats by ochratoxin A and its analogs. Biochim. Biophys. Acta 1357, 225-233.
61. Luhe, A., Hildebrand, H., Bach, U., Dingermann, T., and Ahr, H. J. (2003) A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: expression profiling in vivo and in vitro employing cDNA microarrays. Toxicol. Sci. 73, 315-328.
62. Mally, A., Pepe, G., Ravoori, S., Fiore, M., Gupta, R., Dekant, W., and Mosesso, P. (2005) Ochratoxin A causes DNA damage and cytogenetic effects but no DNA adducts in rats. Chem. Res. Toxicol. 18, 1253-1261.
63. Toyokuni, S., Luo, X. P., Tanaka, T., Uchida, K., Hiai, H., and Lehotay, D. C. (1997) Induction of a wide range of C(2-12) aldehydes and C(7-12) acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Free Radical Biol. Med. 22, 1019-1027.
64. Umemura, T., Takagi, A., Sai, K., Hasegawa, R., and Kurokawa, Y. (1998) Oxidative DNA damage and cell proliferation in kidneys of male and female rats during 13-weeks exposure to potassium bromate (KBrO3). Arch. Toxicol. 72, 264-269.
65. Kasai, H., Nishimura, S., Kurokawa, Y., and Hayashi, Y. (1987) Oral administration of the renal carcinogen, potassium bromate, specifically produces 8-hydroxydeoxyguanosine in rat target organ DNA. Carcinogenesis 8, 1959-1961.
66. Scibelli, A., Tafuri, S., Ferrante, M. C., Alimenti, E., Naso, B., Lucisano, A., Staiano, N., and Della Morte, R. (2003) Ochratoxin A affects COS cell adhesion and signaling. Toxicol. Appl. Pharmacol. 192, 222-230.
67. Dopp, E., Muller, J., Hahnel, C., and Schiffmann, D. (1999) Induction of genotoxic effects and modulation of the intracellular calcium level in syrian hamster embryo (SHE) fibroblasts caused by ochratoxin A. Food Chem. Toxicol. 37, 713-721.
68. Gennari, A., Pazos, P., Boveri, M., Callaghan, R., Casado, J., Maurici, D., Corsini, E., and Prieto, P. (2004) New insights into the mechanisms involved in renal proximal tubular damage induced in vitro by ochratoxin A. J. Biochem. Mol. Toxicol. 18, 43-49.
69. Wurgler, F. E., Friederich, U., and Schlatter, J. (1991) Lack of mutagenicity of ochratoxin A and B, citrinin, patulin and cnestine in Salmonella typhimurium TA102. Mutat. Res. 261, 209-216.
70. Lebrun, S., and Follmann, W. (2002) Detection of ochratoxin A-induced DNA damage in MDCK cells by alkaline single cell gel electrophoresis (comet assay). Arch. Toxicol. 75, 734-741.